As Argo Group Intl Hldgs LTD (AGII) Stock Value Were Volatile, Rothschild Asset Management Has Lifted Position; Edgewood Management Has Cut Position in Vertex Pharmaceuticals (VRTX) by $534,438

May 30, 2018 - By Michael Collier

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Logo

Edgewood Management Llc decreased its stake in Vertex Pharmaceuticals Inc (VRTX) by 8.61% based on its latest 2018Q1 regulatory filing with the SEC. Edgewood Management Llc sold 3,299 shares as the company’s stock declined 7.10% with the market. The institutional investor held 35,000 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $5.70 million, down from 38,299 at the end of the previous reported quarter. Edgewood Management Llc who had been investing in Vertex Pharmaceuticals Inc for a number of months, seems to be less bullish one the $39.86 billion market cap company. The stock increased 0.75% or $1.16 during the last trading session, reaching $156.4. About 27,410 shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 32.80% since May 30, 2017 and is uptrending. It has outperformed by 20.23% the S&P500.




Rothschild Asset Management Inc increased its stake in Argo Group Intl Hldgs Ltd (AGII) by 17.87% based on its latest 2018Q1 regulatory filing with the SEC. Rothschild Asset Management Inc bought 27,320 shares as the company’s stock 0.00% . The institutional investor held 180,217 shares of the finance company at the end of 2018Q1, valued at $10.34M, up from 152,897 at the end of the previous reported quarter. Rothschild Asset Management Inc who had been investing in Argo Group Intl Hldgs Ltd for a number of months, seems to be bullish on the $1.98 billion market cap company. The stock increased 5.37% or $3 during the last trading session, reaching $58.85. About 195,111 shares traded or 27.85% up from the average. Argo Group International Holdings, Ltd. (NASDAQ:AGII) has 0.00% since May 30, 2017 and is . It has underperformed by 12.57% the S&P500.

More news for Argo Group International Holdings, Ltd. (NASDAQ:AGII) were recently published by: Prweb.com, which released: “Corvus® Expands Its InsurTech Product, Smart Cargo Insuranceâ„¢ for Food & Beverage Companies to Reduce Loss of …” on May 30, 2018. Bizjournals.com‘s article titled: “Argo Group invests more in AI, cybersecurity tech” and published on May 08, 2018 is yet another important article.

Rothschild Asset Management Inc, which manages about $4.79B and $8.99 billion US Long portfolio, decreased its stake in Qualcomm Inc (NASDAQ:QCOM) by 325,499 shares to 563,928 shares, valued at $31.25M in 2018Q1, according to the filing. It also reduced its holding in Berkshire Hathaway Inc Del (BRKB) by 6,530 shares in the quarter, leaving it with 105,151 shares, and cut its stake in Supernus Pharmaceuticals Inc (NASDAQ:SUPN).

Among 5 analysts covering Argo Group International Holdings (NASDAQ:AGII), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Argo Group International Holdings had 7 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Argo Group International Holdings, Ltd. (NASDAQ:AGII) earned “Outperform” rating by Wood on Thursday, December 28. The stock of Argo Group International Holdings, Ltd. (NASDAQ:AGII) earned “Overweight” rating by Piper Jaffray on Thursday, December 10. Keefe Bruyette & Woods maintained the shares of AGII in report on Monday, September 18 with “Hold” rating. The stock of Argo Group International Holdings, Ltd. (NASDAQ:AGII) earned “Buy” rating by Keefe Bruyette & Woods on Thursday, December 28. The stock of Argo Group International Holdings, Ltd. (NASDAQ:AGII) earned “Mkt Perform” rating by JMP Securities on Monday, June 27. The firm has “Market Perform” rating by Keefe Bruyette & Woods given on Friday, May 13.

Investors sentiment increased to 2.39 in 2018 Q1. Its up 1.44, from 0.95 in 2017Q4. It increased, as 22 investors sold AGII shares while 24 reduced holdings. 20 funds opened positions while 90 raised stakes. 29.00 million shares or 17.48% more from 24.69 million shares in 2017Q4 were reported. Bluemountain Cap Mgmt Ltd Liability accumulated 936 shares. Eagle Asset reported 0.05% of its portfolio in Argo Group International Holdings, Ltd. (NASDAQ:AGII). State Street Corporation stated it has 812,331 shares or 0% of all its holdings. Voya Investment Ltd Liability Corporation holds 14,338 shares. 36,304 are owned by State Common Retirement Fund. The New York-based D E Shaw And has invested 0.01% in Argo Group International Holdings, Ltd. (NASDAQ:AGII). Tributary Capital Mngmt Lc reported 1.27% of its portfolio in Argo Group International Holdings, Ltd. (NASDAQ:AGII). Prelude Cap Mgmt Ltd Liability Corp accumulated 890 shares. Raymond James & Associates invested in 16,095 shares or 0% of the stock. Thrivent Fincl For Lutherans reported 0.07% in Argo Group International Holdings, Ltd. (NASDAQ:AGII). Fayez Sarofim owns 430,755 shares or 0.13% of their US portfolio. Hotchkis Wiley Mgmt Ltd Limited Liability Company accumulated 30,507 shares or 0.01% of the stock. California Public Employees Retirement Systems invested in 125,490 shares or 0.01% of the stock. Aqr Mngmt Ltd Liability Corporation has 0.01% invested in Argo Group International Holdings, Ltd. (NASDAQ:AGII) for 238,529 shares. Nuveen Asset Ltd invested in 0.15% or 397,383 shares.

Since December 11, 2017, it had 0 insider buys, and 50 selling transactions for $106.45 million activity. 13,750 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares with value of $2.41 million were sold by Sachdev Amit. 2,098 shares were sold by Silva Paul M, worth $342,142 on Monday, February 5. 4,044 shares were sold by Arbuckle Stuart A, worth $614,001. 6,403 shares were sold by ALTSHULER DAVID, worth $965,671. 10,753 shares were sold by Bhatia Sangeeta N., worth $1.68M. 99,563 shares valued at $15.63 million were sold by LEIDEN JEFFREY M on Tuesday, January 16.

Among 30 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 26 have Buy rating, 0 Sell and 4 Hold. Therefore 87% are positive. Vertex Pharmaceuticals had 102 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has “Buy” rating given on Thursday, September 15 by Stifel Nicolaus. The stock has “Buy” rating by BMO Capital Markets on Tuesday, January 2. The company was upgraded on Wednesday, July 19 by Cowen & Co. Piper Jaffray maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) rating on Thursday, February 1. Piper Jaffray has “Buy” rating and $212.0 target. The firm earned “Mkt Perform” rating on Tuesday, September 13 by Raymond James. The company was upgraded on Monday, August 17 by Vetr. The rating was upgraded by Barclays Capital on Wednesday, July 19 to “Overweight”. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Hold” rating by UBS on Wednesday, July 19. The company was upgraded on Friday, June 23 by Needham. On Sunday, July 9 the stock rating was upgraded by Oppenheimer to “Buy”.

More notable recent Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) news were published by: Fool.com which released: “3 Stocks That Could Put Alibaba’s Returns to Shame” on May 26, 2018, also Streetinsider.com with their article: “Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies – RBC” published on May 15, 2018, Streetinsider.com published: “Vertex Pharma (VRTX) Still Looks Best Positioned After CF Deep Dive – JPMorgan” on May 18, 2018. More interesting news about Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) were released by: Nasdaq.com and their article: “3 Top Biotech Stocks to Buy in May” published on May 09, 2018 as well as Investorplace.com‘s news article titled: “The 10 Fastest-Growing Stocks to Invest In Right Now” with publication date: May 22, 2018.

Edgewood Management Llc, which manages about $9.25 billion and $25.05 billion US Long portfolio, upped its stake in Cme Group Inc (NASDAQ:CME) by 251,413 shares to 7.63 million shares, valued at $1.23B in 2018Q1, according to the filing. It also increased its holding in Celgene Corp (NASDAQ:CELG) by 447,445 shares in the quarter, for a total of 11.98 million shares, and has risen its stake in S&P Global Inc.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts